Keyphrases
Multiple Myeloma
100%
T Cells
100%
Immunodeficient
100%
Staphylococcus Aureus
100%
Shock
100%
Mucocutaneous
100%
Cutaneous Signs
100%
Toxic Shock Syndrome
100%
T-cell Mediated
33%
Sepsis Shock
33%
Clinical Symptoms
16%
Bioactive
16%
Cell-derived
16%
Diagnostic Criteria
16%
High-dose Chemotherapy
16%
Specific Activity
16%
Clinical Manifestations
16%
Humoral Immunity
16%
Bone Marrow Transplantation
16%
Multiple Myeloma Patients
16%
M Protein
16%
Superantigen
16%
Immunoglobulin Levels
16%
Life-limiting Conditions
16%
Desquamation
16%
Bacterial Isolates
16%
Broth Culture
16%
Hyperemia
16%
Supernatant Fluid
16%
Cytokine Release
16%
Erythroderma
16%
Mucocutaneous Manifestations
16%
Superantigen Genes
16%
Streptococcal Toxic Shock Syndrome
16%
Superantigen Activity
16%
Medicine and Dentistry
Multiple Myeloma
100%
Shock (Circulatory)
100%
Staphylococcus Aureus
100%
Toxic Shock Syndrome
100%
T Cell
71%
Superantigen
42%
Sepsis
28%
Disease
14%
Diagnosis
14%
Symptom
14%
Cytokine
14%
Polymerase Chain Reaction
14%
High Dose Chemotherapy
14%
Humoral Immunity
14%
Hyperaemia
14%
Immunoglobulin
14%
Desquamation
14%
Bone Marrow Transplantation
14%
M Protein
14%
Erythroderma
14%
Cytokine Release
14%
Immunology and Microbiology
Multiple Myeloma
100%
Staphylococcus Aureus
100%
T Cell
83%
Superantigen
50%
Blood Plasma
33%
Cytokine
16%
Immunoglobulin Blood Level
16%
Drug Megadose
16%
Humoral Immunity
16%
Polymerase Chain Reaction
16%
Bone Marrow Transplantation
16%
Liquid
16%
Cytokine Release
16%
Desquamation
16%